DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01536535 (ClinicalTrials.gov)	July 10, 2012	16/2/2012	Predicting Response to Standardized Pediatric Colitis Therapy	Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.	Ulcerative Colitis	Drug: Mesalazine;Drug: IV Corticosteroid;Drug: Oral Corticosteroids;Other: Additional Therapies;Procedure: Colectomy	Connecticut Children's Medical Center	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Completed	4 Years	17 Years	All	431	Phase 4	United States;Canada

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT01536535
(ClinicalTrials.gov)

July 10, 2012

16/2/2012

Predicting Response to Standardized Pediatric Colitis Therapy

Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.

Ulcerative Colitis

Drug: Mesalazine;Drug: IV Corticosteroid;Drug: Oral Corticosteroids;Other: Additional Therapies;Procedure: Colectomy

Connecticut Children's Medical Center

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

4 Years

17 Years

All

431

Phase 4

United States;Canada